Medtronic goes to the Federal Circuit to seek avenues for reversing a $10 million patent infringement loss over angiography catheters.
Medical device giant Medtronic (NYSE:MDT) is looking for avenues to reverse a $10 million patent infringement loss over angiography catheters.
In January 2012 an Oklahoma jury ordered Medtronic to pay $9.9 million in back royalties for willfully infringing on a guidance catheter patent owned by Dr. Jan Voda, a decision that the company said it would seek to overturn.